Glycemia reduction in type 2 Diabetes - Microvascular and cardiovascular outcomes
Other Ingredients: Diluent [INS 460(i)],, Binding agent [INS 1202], Diluent [Lactose Monohydrate], Glidant [INS 553 (i)],, Coating Agent [INS 464], Colour [INS 172 (ii)], Diluent [INS 170], Vehicle [INS 477], Glidant [553 (ii)], Binding Agent [1201], Natural flavour [Strawberry], Coating agent [INS 462], Antisticking agent [470 (iii)] and Solvent [Isopropyl alcohol, Dichloromethane]
Avexitide is designed to bind to the GLP-1 receptor on pancreatic islet beta cells and block the effect of excessive GLP-1 to mitigate hypoglycemia by decreasing insulin secretion and stabilizing glucose levels
A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development